Literature DB >> 19747382

Nested-multiplex PCR detection of Orthopoxvirus and Parapoxvirus directly from exanthematic clinical samples.

Jônatas S Abrahão1, Larissa S Lima, Felipe L Assis, Pedro A Alves, André T Silva-Fernandes, Marcela M G Cota, Vanessa M Ferreira, Rafael K Campos, Carlos Mazur, Zélia I P Lobato, Giliane S Trindade, Erna G Kroon.   

Abstract

BACKGROUND: Orthopoxvirus (OPV) and Parapoxvirus (PPV) have been associated with worldwide exanthematic outbreaks. Some species of these genera are able to infect humans and domestic animals, causing serious economic losses and public health impact. Rapid, useful and highly specific methods are required to detect and epidemiologically monitor such poxviruses. In the present paper, we describe the development of a nested-multiplex PCR method for the simultaneous detection of OPV and PPV species directly from exanthematic lesions, with no previous viral isolation or DNA extraction. METHODS AND
RESULTS: The OPV/PPV nested-multiplex PCR was developed based on the evaluation and combination of published primer sets, and was applied to the detection of the target pathogens. The method showed high sensitivity, and the specificity was confirmed by amplicon sequencing. Exanthematic lesion samples collected during bovine vaccinia or contagious ecthyma outbreaks were submitted to OPV/PPV nested-multiplex PCR and confirmed its applicability.
CONCLUSION: These results suggest that the presented multiplex PCR provides a highly robust and sensitive method to detect OPV and PPV directly from clinical samples. The method can be used for viral identification and monitoring, especially in areas where OPV and PPV co-circulate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747382      PMCID: PMC2749831          DOI: 10.1186/1743-422X-6-140

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


Background

Orthopoxvirus (OPV) and Parapoxvirus (PPV) consist of large, enveloped, linear double-stranded DNA viruses, and are classified as genera of the family Poxviridae [1]. Several species included in these genera are related with worldwide acute exanthematic disease in humans and domestic animals, which cause serious economic losses and impact public health [1,2]. There are three zoonotic OPV species known, Monkeypox virus (MPXV), Cowpox virus (CPXV) and Vaccinia virus (VACV), and their presence is associated with an increased number of outbreaks in Africa, Europe, South America and Asia [3-6]. Similarly, several zoonotic PPV infections have been noted, and are caused mainly by Bovine papular stomatitis virus (BPSV), Orf virus (ORFV) and Pseudocowpox virus (PSCV) [7,8]. Even though humans are susceptible to MPXV, CPXV, VACV, BPSV, ORFV and PSCV, domestic animals such as sheep, goats, cats, dogs and dairy cattle can be infected by some OPV and/or PPV since the host-range of these viruses is large and incompletely known [9]. OPV and PPV transmission is usually promoted by fomites or direct contact, and the infected humans play an important role in viral spread among domestic animals, especially during milking and other occupational livestock activities [1,9]. Clinically, the exanthematic lesions caused by zoonotic OPV and PPV species are very similar, especially in humans and cows, and these can be critical for diagnosis in areas with OPV/PPV co-circulation [7,10-12]. Both OPV and PPV cause local or disseminated vesicular-pustular lesions that are associated with fever, lymphadenopathy, malaise and acute muscle pain [9]. Therefore, the OPV/PPV differential diagnosis involves serological, virological, microscopical and molecular techniques [5,7,8,11,13-16]. Although serological methods such as ELISAs, immunofluorescence assays and neutralization tests are useful and widely applied to OPV and PPV diagnosis, these techniques cannot differentiate anti-OPV antibodies resulting from acute infection from anti-OPV antibodies resulting from a prior vaccination [17]; additionally, the titer of anti-PPV neutralizing antibodies can promptly decrease to undetectable levels a few months after the infection [18]. Though the other molecular diagnostic approaches mentioned are also valuable and specific, they usually require viral isolation and/or DNA manipulation, and are designed to detect specifically OPV or PPV. In the present work, we report the development of a nested-multiplex PCR system for the sensitive and reliable detection of OPV and PPV based on the combination and optimization of published primer sets. We also report its application for the detection of viruses included in these genera directly from bovine, ovine, caprine and human exanthematic lesions with no viral isolation or DNA manipulation. Sixty-eight clinical samples collected during Brazilian bovine Vaccinia (BV) or contagious ecthyma (CE) outbreaks were used to evaluate the performance of the OPV/PPV nested multiplex PCR and confirm its applicability to viral identification and monitoring.

Methods and Results

Multiplex PCR setting and sensitivity tests

The OPV/PPV multiplex PCR was designed based on computer simulation of different combinations of several published primer pairs, using software available online [19]. Two exclusive and highly conserved genes were targeted by nested-multiplex PCR: the OPV viral growth factor (vgf) and the PPV major viral glycoprotein (b2l); these genes have been widely used in OPV and PPV diagnosis and phylogenetic analysis (Table 1). The nested-multiplex PCR was carried out in a two-step reaction protocol. In the first step, the OPV primers vgfF and vgfR [20] were used in association with the PPV primers OVB2LF1 and OVB2LR1 [21]. In the nested step, a pair of internal OPV primers (vgfF2: ACACGGTGACTGTATCCA and vgfR2: CTAATACAAGCATAATAC) were designed from alignment of the vgf sequences of Brazilian VACV strains (Drumond and others, data not published) and other available OPV sequences (GenBank accession nos. [AY243312.1 (VACV-WR); AY678276.1 (VACV-LISTER); DQ792504.1 (Horsepox virus - HSPV); AY484669.1 (Rabbitpox virus - RPV); DQ437590.1 (VARV); AF482758.2 (CPXV)]); these primers were then used in association with the PPV primers PPP-1 and PPP-4 [7]. Several chemical and thermal conditions were evaluated. The best conditions were established based on amplicon yield and specificity [corresponding to the expected fragments of 170 bp (OPV) and 592 pb (PPV)], described as follows. In the first step, 2 μL of template were added to 18 μL of the PCR reaction mixture containing 0.4 mM of OPV primers (VGF-F and VGF-R), 0.8 mM of PPV primers (OVB2LF1 and OVB2LR1), 10 mM dNTPs, 2.0 mM MgCl2, 500 ng Bovine Serum Albumin (BSA) and 2 U of Taq DNA polymerase (Promega, Madison, USA), using the manufacturer's supplied 10× buffer. Reactions were performed with a DNA Mastercycler Epgradient (Eppendorf, Hamburg, Germany) using the following protocol: incubation at 95°C for 9 min; 30 cycles of denaturation (94°C, 1 min), annealing (45°C, 1 min) and extension (72°C, 1 min); final extension (72°C, 10 min). The nested PCR step was carried out using 1 μL of undiluted first PCR product as template. The same chemical and thermal conditions were used, but using internal OPV (vgfF2 and vgfR2 - 0.4 mM) and PPV (PPP-1 and PPP-4 - 0.8 mM) primers. The PCR products were electrophoresed on 8% PAGE gels and silver stained [22]. These same conditions were used in sensitivity tests. Some reactions were performed with the addition of both PPV and OPV scabs, with the purpose of simulating a possible co-infection. In order to confirm the OPV/PPV specificity, other exanthematic infectious agents were submitted to PCR: (i) a Bovine herpes virus positive scab kindly provided by Dr. Z. Lobato (Minas Gerais Federal University, Brazil), and (ii) a Brazilian Sthaphylococcus aureus strain, isolated from a hospital infection, kindly provided by Dr. L. Parucker (Santa Catarina Federal University, Brazil).
Table 1

Selected primers for the OPV/PPV nested-multiplex PCR

GenusTarget genePrimer sequence (5' - 3')Reference
OPVvgf1st stepvgfF: CGCTGCTATGATAATCAGATCATTFonseca et al., 1998
vgfR: GATATGGTTGTGCCATAATTTTTAT
Nested stepvgfF2: ACACGGTGACTGTATCCAThis study
vgfR2: CTAATACAAGCATAATAC
PPVb2l1st stepOVB2LF1: TCCCTGAAGCCCTATTATTTTTGTHosamani et al., 2006
OVB2LR1: GCTTGCGGGCGTTCGGACCTTC
Nested stepPPP-1: GTCGTCCACGATGAGCAGInoshima et al., 2000
PPP-4: TACGTGGGAAGCGCCTCGCT
Selected primers for the OPV/PPV nested-multiplex PCR The PCR sensitivity tests were performed using serial dilutions of the vgf and b2l external fragments cloned in the pGEM-T easy vector (Promega, Madison, WI, USA). These constructs were obtained by PCR amplification [20,21] from BV and CE outbreaks exanthematic lesions, followed by purification of the PCR products (QIAquick Gel Extraction Kit - QIAGEN, California - U.S.A.) and cloning into the pGEM-T easy vector. Three clones of each sample were sequenced in both orientations using M13 universal primers (Mega-BACE sequencer, GE Healthcare, Buckinghamshire, UK), and confirmed the PCR specificity. The vgf and b2l fragments were quantified (ND1000 spectrophotometer, Thermofisher Scientific - Massachusetts, U.S.A.) and submitted to OPV/PPV nested-multiplex PCR under distinct concentrations - 50, 25, 10, 5, 2 and 1 ng. The PCR products were electrophoresed on 8% PAGE gels and silver stained [22]. Fragments of approximately 170 bp and 592 bp that correspond to the vgf and b2l genes, respectively, were specifically amplified best by PCR under the described thermal and chemical conditions (Figure 1-A). The amplified fragment sequences showed 100% identity with the VACV vgf gene (AY2433121 and others) or the ORFV b2l gene (FJ665818 and others). Reactions in which OPV and PPV scabs were added presented the amplification of both the170 and 592 bp fragments. No specific viral bands were observed in the negative control or in the in Bovine herpes virus and S. aureus reactions. Sensitivity tests using vgf or b2l cloned fragments presented unique and specific amplified bands of approximately 170 bp and 592 bp, respectively. In both cases, the PCR was able to detect until 1 ng of viral DNA fragment (Figure 1-B). No specific viral bands were observed in sensitivity test negative controls.
Figure 1

(A) OPV/PPV nested-multiplex standardization and (B) sensitivity tests. Exanthematic lesions from BV and CE outbreaks were used in PCR standardization and sensitivity assays. Different thermal and chemical conditions were tested. (A) lane 1-3: BV scabs and vesicles presenting OPV vgf gene amplification (170 bp); lane 4-6: CE scabs presenting PPV b2l gene amplification (592 bp); lane 7: negative control; lane 8-9: BV and CE scabs, simulating a possible co-infection, presenting the simultaneous amplification of OPV vgf and PPV b2l genes. (B) PCR sensitivity tests performed with different concentrations of vgf or b2l fragments. The nested-multiplex was able to detect OPV and PPV DNA until reactions in which there was 1 ng of vgf or b2l genes. The PCR products were electrophoresed on 8% PAGE gels and silver stained. NC: negative control.

(A) OPV/PPV nested-multiplex standardization and (B) sensitivity tests. Exanthematic lesions from BV and CE outbreaks were used in PCR standardization and sensitivity assays. Different thermal and chemical conditions were tested. (A) lane 1-3: BV scabs and vesicles presenting OPV vgf gene amplification (170 bp); lane 4-6: CE scabs presenting PPV b2l gene amplification (592 bp); lane 7: negative control; lane 8-9: BV and CE scabs, simulating a possible co-infection, presenting the simultaneous amplification of OPV vgf and PPV b2l genes. (B) PCR sensitivity tests performed with different concentrations of vgf or b2l fragments. The nested-multiplex was able to detect OPV and PPV DNA until reactions in which there was 1 ng of vgf or b2l genes. The PCR products were electrophoresed on 8% PAGE gels and silver stained. NC: negative control.

Nested-multiplex applicability tests: clinical samples from exanthematic outbreaks

Vesicle contents and dried scabs from cattle udders and milkers' hands were collected during Brazilian BV outbreaks or from sheep and goats during CE outbreaks. This collection was accomplished using 1-ml insulin syringes, 0.45 mm×13 mm needles, and cotton swabs or a pair of forceps. Collected samples were chilled, transported to the laboratory, and stored at -70°C until processed. Vesicular liquid swabs were added to 200 μL of PBS and centrifuged at 2000 × g for 3 min. Scabs were macerated by a homogenizer (Politron, Littau, Switzerland) in PBS (0.1 g scab/0.9 mL PBS) and clarified by centrifugation at 2000 × g for 3 min. Two microliters of the supernatants were used in the nested-multiplex PCR. Some expected PCR products were directly sequenced (ET Dynamic Terminator for MegaBACE - GE Healthcare, Fairfield, USA) and compared with available GenBank sequences using an online blast program . To avoid any possibility of laboratory cross-contamination, the different samples were manipulated separately. A total of 64 clinical samples were collected and then submitted to OPV/PPV nested-multiplex PCR (Table 2). Of these samples, 56 were collected during BV outbreaks (36 from bovines and 20 from humans) and 8 samples were collected during CE outbreaks (3 from caprines and 5 from ovines). All collected BV and CE clinical samples were previously tested by other molecular methods (Fonseca et al., 1998; Inoshima et al., 2000) and were confirmed VACV and ORFV infections, respectively. Among the BV clinical samples, the OPV/PPV nested-multiplex PCR detected OPV DNA in 53 scabs/vesicles (94.4%). The multiplex was able to detect PPV DNA in all analyzed CE clinical samples. Considering all bovine, human, ovine and caprine samples, the nested-multiplex PCR presented a positivity of 95.3%. The sequences of the amplified fragments again confirmed the PCR specificity, showing high identity with the VACV vgf gene or the ORFV b2l gene sequences. No co-infection case was detected in this molecular screening.
Table 2

Clinical samples used to evaluated the performance of the OPV/PPV nested-multiplex PCR

State/YearN° of specimensSourceaDesignationSpecimenPositive samplesResultReference
Minas Gerais, 20052BGP1V, GP2Vscab2OPVTrindade et al., 2006
Minas Gerais, 200511B/HSVscab and vesicle10OPVTrindade et al., 2007
Minas Gerais, 20031BPSTVscab1OPVLeite et al., 2005
Minas Gerais, 200513B/HMARVscab and vesicle11OPVAbrahão et al., upubl. Data
Espírito Santos, 20084B/HLINVscab and vesicle5OPVAbrahão et al., upubl. Data
Minas Gerais, 20055B/HRPLVscab and vesicle5OPVAbrahão et al., upubl. Data
Minas Gerais, 20058B/HJQRVscab and vesicle7OPVAbrahão et al., upubl. Data
Minas Gerais, 20088BPRGVscab8OPVAbrahão et al., upubl. Data
Minas Gerais, 20084HARGVvesicle4OPVAbrahão et al., upubl. Data
Minas Gerais, 19901CORF-Asacb1PPVMazur & Machado, 1990
Pernambuco, 19932CNE1, NE2scab2PPVMazur et al., 2000
Mato Grosso, 20055OMT05scab5PPVAbrahão et al., 2009
Total64Positivity 61 (95,31%)

B = bovine; H = human; C = caprine; O = ovine

Clinical samples used to evaluated the performance of the OPV/PPV nested-multiplex PCR B = bovine; H = human; C = caprine; O = ovine

Conclusion

In the present work, the creation of a multiplex PCR method for the simultaneous detection of OPV and PPV has been described and tested with exanthematic clinical samples from distinct viral hosts, with no DNA extraction or virus manipulation. The method proposed was able to correctly identify the target pathogens by amplification of conserved genes, even in co-infection simulations. The primer selection and multiplex optimization allowed the creation of a robust method, with performances comparable to conventional one-pathogen PCR assays [7,20]. The sequencing of vgf and b2l amplicons confirmed the specificity of the nested-multiplex approach. The sensitivity and robustness of the proposed method, together with its ability to perform well on exanthematic clinical samples, make it a suitable method to rapidly identify and effectively monitor OPV and PPV infection outbreaks.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JSA, LSL, GST and EGK participated in the planning of the project. EGK was the leader of the project. ZIPL and CM collected the samples. JSA, LSL, FSS, PAA, ATSF, MMGC, VMF and RCK performed the PCR and phylogenetic analysis. All authors read and approved the final manuscript.
  17 in total

1.  Detection and diagnosis of parapoxvirus by the polymerase chain reaction.

Authors:  Y Inoshima; A Morooka; H Sentsui
Journal:  J Virol Methods       Date:  2000-02       Impact factor: 2.014

2.  Orthopoxvirus infection transmitted by a domestic cat.

Authors:  Holger A Haenssle; Judith Kiessling; Volkhard A J Kempf; Thomas Fuchs; Christine Neumann; Steffen Emmert
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

Review 3.  Re-emergence of monkeypox in Africa: a review of the past six years.

Authors:  D L Heymann; M Szczeniowski; K Esteves
Journal:  Br Med Bull       Date:  1998       Impact factor: 4.291

4.  Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.

Authors:  Giliane de Souza Trindade; Flávio Guimarães da Fonseca; João Trindade Marques; Maurício Lacerda Nogueira; Luiz Claudio Nogueira Mendes; Alexandre Secorun Borges; Juliana Regina Peiró; Edviges Maristela Pituco; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

5.  Morphological and molecular characterization of the poxvirus BeAn 58058.

Authors:  F G Fonseca; M C Lanna; M A Campos; E W Kitajima; J N Peres; R R Golgher; P C Ferreira; E G Kroon
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

Review 6.  Ovine diseases. Orf.

Authors:  D M Haig; A A Mercer
Journal:  Vet Res       Date:  1998 May-Aug       Impact factor: 3.683

7.  Monkeypox virus detection in rodents using real-time 3'-minor groove binder TaqMan assays on the Roche LightCycler.

Authors:  David A Kulesh; Bonnie M Loveless; David Norwood; Jeffrey Garrison; Chris A Whitehouse; Chris Hartmann; Eric Mucker; David Miller; Leonard P Wasieloski; John Huggins; Gregory Huhn; Lori L Miser; Carroll Imig; Mark Martinez; Tom Larsen; Cynthia A Rossi; George V Ludwig
Journal:  Lab Invest       Date:  2004-09       Impact factor: 5.662

8.  Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Authors:  David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John Huggins; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 9.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

10.  Detection and phylogenetic analysis of Orf virus from sheep in Brazil: a case report.

Authors:  Jônatas S Abrahão; Rafael K Campos; Giliane S Trindade; Maria I M Guedes; Zélia I P Lobato; Carlos Mazur; Paulo C P Ferreira; Cláudio A Bonjardim; Erna G Kroon
Journal:  Virol J       Date:  2009-05-04       Impact factor: 4.099

View more
  13 in total

1.  Group 1 Vaccinia virus zoonotic outbreak in Maranhao State, Brazil.

Authors:  Danilo Bretas Oliveira; Felipe Lopes Assis; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Am J Trop Med Hyg       Date:  2013-10-28       Impact factor: 2.345

2.  Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.

Authors:  Hye-Young Wang; Sangjung Park; Sunghyun Kim; Sungwoo Ahn; Dongsup Lee; Seungil Kim; Dongju Jung; Kwang Hwa Park; Hyeyoung Lee
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Serologic evidence of orthopoxvirus infection in buffaloes, Brazil.

Authors:  Felipe Lopes de Assis; Graziele Pereira; Cairo Oliveira; Gisele Olinto Libânio Rodrigues; Marcela Menezas Gomes Cotta; Andre Tavares Silva-Fernandes; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

4.  Vaccinia virus Transmission through Experimentally Contaminated Milk Using a Murine Model.

Authors:  Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Ana Luiza Soares Fraiha; Aristóteles Gomes Costa; Ana Carolina Diniz Matos; Aparecida Tatiane Lino Fiúza; Zélia Inês Portela Lobato
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

5.  Outbreak of severe zoonotic vaccinia virus infection, Southeastern Brazil.

Authors:  Jônatas Santos Abrahão; Rafael Kroon Campos; Giliane de Souza Trindade; Flávio Guimarães da Fonseca; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

6.  Vaccinia virus in Feces and Urine of Wild Rodents from São Paulo State, Brazil.

Authors:  Marina G Peres; Thais S Bacchiega; Camila M Appolinário; Acácia F Vicente; Mateus S R Mioni; Bruna L D Ribeiro; Clóvis R S Fonseca; Vanessa C Pelícia; Fernando Ferreira; Jonatas S Abrahão; Jane Megid
Journal:  Viruses       Date:  2018-01-23       Impact factor: 5.048

7.  Characterization of a new Vaccinia virus isolate reveals the C23L gene as a putative genetic marker for autochthonous Group 1 Brazilian Vaccinia virus.

Authors:  Felipe L Assis; Gabriel M F Almeida; Danilo B Oliveira; Ana P M Franco-Luiz; Rafael K Campos; Maria I M Guedes; Flávio G Fonseca; Giliane S Trindade; Betânia P Drumond; Erna G Kroon; Jônatas S Abrahão
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

8.  Reemergence of vaccinia virus during Zoonotic outbreak, Pará State, Brazil.

Authors:  Felipe L de Assis; Wagner M Vinhote; José D Barbosa; Cairo H S de Oliveira; Carlos M G de Oliveira; Karinny F Campos; Natália S Silva; Giliane de Souza Trindade
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

9.  Vaccinia virus in household environment during bovine vaccinia outbreak, Brazil.

Authors:  Felipe L Assis; Iara A Borges; Vaz S Mesquita; Paulo C Ferreira; Giliane S Trindade; Erna G Kroon; Jonatas S Abrahão
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

10.  Vaccinia Virus in Blood Samples of Humans, Domestic and Wild Mammals in Brazil.

Authors:  Marina G Peres; Thais S Bacchiega; Camila M Appolinário; Acácia F Vicente; Mateus de Souza Ribeiro Mioni; Bruna L D Ribeiro; Clóvis R S Fonseca; Vanessa C Pelícia; Fernando Ferreira; Graziele P Oliveira; Jonatas S Abrahão; Jane Megid
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.